Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

GSK's Launches, Global Expansion Drive Consumer Sales Ahead Of Market

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Brand innovation, continued investment in marketing and global expansion help drive up GlaxoSmithKline's consumer health care sales significantly faster than overall market growth, the firm says

You may also be interested in...



Glaxo's Stiefel Labs Touts Penetrating Foam In MaxClarity Acne Treatment

Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam

Glaxo's Stiefel Labs Touts Penetrating Foam In MaxClarity Acne Treatment

Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam

Glaxo's Stiefel Labs Touts Penetrating Foam In MaxClarity Acne Treatment

Stiefel Laboratories differentiates its MaxClarity Acne Management System with VersaFoam technology to deliver active ingredients in foam

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet

Topics

Tags:
OTC Drugs
Latest Headlines

Are Regulators Ready For The Robot Era? ChatGPT Weighs In On EU Regulation

Pink Sheet Podcast: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings

Recent And Upcoming FDA Advisory Committee Meetings

EU CHMP Opinions and MAA Updates

See All
UsernamePublicRestriction

Register

PS104068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By